Brief: Lyra Therapeutics reports Q2 results

Lyra Therapeutics

09/08/2022 12:36

Aug 9 (Reuters) - Lyra Therapeutics Inc  LYRA.O :
    * LYRA THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * CASH AND CASH EQUIVALENTS AS OF JUNE 30, 2022 WERE $120.7
MILLION
    * EXPECTS ITS CASH AND CASH EQUIVALENTS BALANCE TO BE
SUFFICIENT
TO FUND ITS PLANNED OPERATIONS THROUGH MID-2024
    * QTRLY LOSS PER SHARE $0.43
    * Q2 EARNINGS PER SHARE VIEW $-0.37 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn9tDrgWa 
Further company coverage:  LYRA.O